INSTEM PLC - ORD 10P
INSTEM PLC - ORD 10P
Share · GB00B3TQCK30 (XLON)
Overview Financial Indicators
No Price
Closing Price XLON 17.11.2023: 829,00 GBX
n/a

Current Prices from INSTEM PLC - ORD 10P

ExchangeTickerCurrencyLast TradePriceDaily Change
XLON: London
London
INS.L
GBX
17.11.2023 16:29
829,00 GBX
0,00 GBX

Performance

Day Week Month 3 Months 6 Months 1 Year 5 Years
0,00 % 0,00 % - - -0,12 % -0,12 % 69,18 %

Company Profile for INSTEM PLC - ORD 10P Share

Instem plc, together with its subsidiaries, provides information technology applications to the life sciences healthcare market worldwide. The company offers solutions for data collection, management, and analysis to meet the needs of life science and healthcare organizations for data-driven decision making. Its solutions include ALPHADAS, an eSource system for early phase clinical trials; BioRails for discovery data management; Comet Assay IV, a live video imaging system for reproducible comet slide scoring; and Cyto Study Manager, a data acquisition and reporting solution. The company also offers computational toxicology products and services; Logbook, a repository for information; Morphit for discovery data visualization; NOTOCORD-hem software platforms to acquire, display, and analyze physiological signals; and Provantis, a Windows-based system for organizations and universities in non-clinical evaluation studies. In addition, it provides Samarind RMS to manage medical product information; submit platform that offers tools and services for the creation and management of SEND datasets and associated documents for contract research organizations and sponsors; SENDView, an application that simplifies the review of SEND datasets; SEND Explorer, a web-based application with optional data warehousing capabilities; SENDTrial, a web based solution that can be accessed through a subscription; and standard for exchange of nonclinical data solutions. Further, the company provides Sorcerer Colony Counter for automatic plate counter; sales support, training, validation, consultancy, cloud, and safety assessment and regulatory information management software services; and software solutions to extract intelligence from research and development related healthcare data. It also develops, manufactures, and supplies software and hardware products for in vitro study data collection and management. Instem plc was founded in 1969 and is headquartered in Stone, the United Kingdom.

Company Data

Name INSTEM PLC - ORD 10P
Company Instem plc
Website https://www.instem.com
Primary Exchange XLON London
ISIN GB00B3TQCK30
Asset Class Share
Sector Healthcare
Industry Medical - Healthcare Information Services
CEO Mr. Phil J. Reason
Market Capitalization 199 Mio
Country United Kingdom
Currency GBP
Employees 0,5 T
Address Diamond Way, ST15 0SD Stone
IPO Date 2010-01-12

Ticker Symbols

Name Symbol
London INS.L

More Shares

Investors who INSTEM PLC - ORD 10P hold also have the following shares in their portfolio:
BNZ INTL FDG. 19/22 MTN
BNZ INTL FDG. 19/22 MTN Bond
GREIF NEVADA H.11/21 REGS
GREIF NEVADA H.11/21 REGS Bond
The financial platform MoneyPeak tracks and analyzes investments and portfolios. From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.
Imprint Data Protection Blog Community Feedback Changelog
Im App Store herunterladen Bei Google Play herunterladen
All rights reserved © LCP GmbH 2025